"Hearing Loss" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A general term for the complete or partial loss of the ability to hear from one or both ears.
Descriptor ID |
D034381
|
MeSH Number(s) |
C09.218.458.341 C10.597.751.418.341 C23.888.592.763.393.341
|
Concept/Terms |
Hearing Loss- Hearing Loss
- Loss, Hearing
- Hypoacusis
- Hypoacuses
- Hearing Impairment
|
Below are MeSH descriptors whose meaning is more general than "Hearing Loss".
Below are MeSH descriptors whose meaning is more specific than "Hearing Loss".
This graph shows the total number of publications written about "Hearing Loss" by people in this website by year, and whether "Hearing Loss" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 0 | 1 |
2004 | 1 | 2 | 3 |
2005 | 2 | 0 | 2 |
2006 | 1 | 1 | 2 |
2007 | 1 | 0 | 1 |
2008 | 3 | 0 | 3 |
2009 | 0 | 2 | 2 |
2010 | 4 | 4 | 8 |
2011 | 3 | 1 | 4 |
2012 | 2 | 0 | 2 |
2013 | 4 | 2 | 6 |
2014 | 4 | 0 | 4 |
2015 | 6 | 1 | 7 |
2016 | 9 | 3 | 12 |
2017 | 9 | 1 | 10 |
2018 | 12 | 0 | 12 |
2019 | 13 | 3 | 16 |
2020 | 10 | 0 | 10 |
2021 | 13 | 1 | 14 |
2022 | 14 | 0 | 14 |
2023 | 12 | 0 | 12 |
2024 | 8 | 2 | 10 |
2025 | 11 | 1 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hearing Loss" by people in Profiles.
-
Reproductive milestones, use of menopausal hormone therapy, and risk of hearing loss: A life course study of 214 327 women. Maturitas. 2025 Oct; 201:108685.
-
Associations of Traumatic Brain Injury and Hearing: Results From the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). J Head Trauma Rehabil. 2025 Jul-Aug 01; 40(4):287-295.
-
Hearing Intervention, Social Isolation, and Loneliness: A Secondary Analysis of the ACHIEVE Randomized Clinical Trial. JAMA Intern Med. 2025 Jul 01; 185(7):797-806.
-
Effects of hearing intervention on falls in older adults: findings from a secondary analysis of the ACHIEVE randomised controlled trial. Lancet Public Health. 2025 Jun; 10(6):e492-e502.
-
Development and Validation of a Novel Prediction Model for Hearing Loss From Cisplatin Chemotherapy. J Clin Oncol. 2025 Jul; 43(19):2173-2183.
-
Impact of a Hearing Intervention on the Levels of Leisure-Time Physical Activity and T.V. Viewing in Older Adults: Results from a Secondary Analysis of the ACHIEVE Study. J Gerontol A Biol Sci Med Sci. 2025 May 05; 80(6).
-
Cognitive benefits of hearing intervention vary by risk of cognitive decline: A secondary analysis of the ACHIEVE trial. Alzheimers Dement. 2025 May; 21(5):e70156.
-
The Medial Olivocochlear Efferent Pathway Potentiates Cochlear Amplification in Response to Hearing Loss. J Neurosci. 2025 Apr 09; 45(15).
-
Effects of Hearing Intervention on Physical Activity Measured by Accelerometry: A Secondary Analysis of the ACHIEVE Study. J Am Geriatr Soc. 2025 Jun; 73(6):1762-1771.
-
Feasibility and Safety of Intratympanic Administration of Sustained-Exposure Dexamethasone Thermosensitive Gel (OTO-104) for Prevention of Cisplatin-Induced Hearing Loss in Children: A Multisite Phase 2 Randomized Clinical Trial. Pediatr Blood Cancer. 2025 Jun; 72(6):e31680.